FDA Drug Application (205777) for TARGINIQ by PURDUE PHARMA LP

Back to FDA Applications sponsored by PURDUE PHARMA LP

Application Number205777
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage5MG;10MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTARGINIQ
Active IngredientNALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient NALOXONE HYDROCHLORIDE12
List of drugs with Active Ingredient OXYCODONE HYDROCHLORIDE27


Back to FDA Applications sponsored by PURDUE PHARMA LP